OLUX Drug Patent Profile

✉ Email this page to a colleague

When do Olux patents expire, and what generic alternatives are available?

Olux is a drug marketed by Norvium Bioscience and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in OLUX is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Olux

A generic version of OLUX was approved as clobetasol propionate by COSETTE on February 16^th, 1994.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for OLUX?
What are the global sales for OLUX?
What is Average Wholesale Price for OLUX?

Summary for OLUX

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	80
Patent Applications:	4,476
Drug Prices:	Drug price information for OLUX
What excipients (inactive ingredients) are in OLUX?	OLUX excipients list
DailyMed Link:	OLUX at DailyMed

Drug patent expirations by year for OLUX

Paragraph IV (Patent) Challenges for OLUX

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
OLUX	Topical Foam	clobetasol propionate	0.05%	021142	1	2005-06-27

US Patents and Regulatory Information for OLUX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Norvium Bioscience	OLUX	clobetasol propionate	AEROSOL, FOAM;TOPICAL	021142-001	May 26, 2000		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Norvium Bioscience	OLUX E	clobetasol propionate	AEROSOL, FOAM;TOPICAL	022013-001	Jan 12, 2007		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Norvium Bioscience	OLUX E	clobetasol propionate	AEROSOL, FOAM;TOPICAL	022013-001	Jan 12, 2007		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for OLUX

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Norvium Bioscience	OLUX	clobetasol propionate	AEROSOL, FOAM;TOPICAL	021142-001	May 26, 2000	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for OLUX

See the table below for patents covering OLUX around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Mexico	9706698	COMPOSICION FARMACEUTICA QUE CONTIENE CORTICOSTEROIDES. (CORTICOSTEROID-CONTAINING PHARMACEUTICAL COMPOSITION.)	⤷ Sign Up
Australia	4885196		⤷ Sign Up
Hungary	228890	CORTICOSTEROID-CONTAINING FOAM AND USE THEREOF	⤷ Sign Up
Portugal	813413		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for OLUX

Paragraph IV (Patent) Challenges for OLUX

Make Better Decisions: Try a trial or see plans & pricing